Abstracts tagged "Prevalence"

Abstract Number: 0149 • ACR Convergence 2021
Development of Joint Effusion, Hyperperfusion and Enthesitis After One Hour of Age-and Gender Adjusted Weight Training
Julia Schreiner¹, Dennis Scheicht², Pantelis Karakostas³, Jana Ziob¹, Charlotte Behning¹, Peter Preuss⁴, Peter Brossart⁵ and Valentin Schäfer¹, ¹University Hospital Bonn, Bonn, Germany, ²Porz am Rhein Hospital, Cologne, Germany, ³Clinic of Internal Medicine III, Oncology, Haematology, Rheumatology and Clinical Immunology, University Hospital Bonn, Bonn, Germany, ⁴University of Bonn, Bonn, Germany, ⁵Department of Internal Medicine III, Oncology, Hematology and Rheumatology, University Hospital Bonn, Bonn, Germany
Background/Purpose: Ultrasound is an established tool to detect changes of joints, tendons and entheses in rheumatology. However, several studies detected structural and vascular changes in…
Abstract Number: 0332 • ACR Convergence 2021
Prevalence of Systemic Lupus Erythematosus in the United States: Updated Population Representative Estimates from the Medical Expenditure Panel Survey (MEPS) 2016-2018
Michael Pollack¹, Sandra Sze-jung Wu¹, Eilleen Farrelly², Shannon Grabich³ and Robert Ortmann⁴, ¹AstraZeneca, Wilmington, DE, ²Xcenda, Carrollton, TX, ³Xcenda, Durham, NC, ⁴AstraZeneca, Greenwood, IN
Background/Purpose: Systemic lupus erythematosus (SLE) is a chronic, multi-organ, autoimmune disease whose prevalence in the US has not been recently updated in real-world studies. Prevalence…
Abstract Number: 1785 • ACR Convergence 2021
Prevalence and Incidence of PsA in Germany – a Cohort Study with 65 Million Participants
Madeline Denke¹, Matthias Schneider², Ralph Brinks¹ and Philipp Sewerin³, ¹Department for Rheumatology, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany, ²Policlinic & Hiller Research Unit Rheumatology, UKD, Heinrich-Heine University, Düsseldorf, Germany, ³Department and Hiller Research Unit of Rheumatology, Heinrich Heine University Duesseldorf, Duesseldorf, Germany
Background/Purpose: Patients suffering from Psoriatic-Arthritis (PsA) can experience a substantial burden of disease, which may result in a significant reduction of their quality of life.…
Abstract Number: 176 • 2019 ACR/ARP Annual Meeting
The Epidemiology of Rheumatoid Arthritis in the Czech Republic
Jakub Závada¹, Monika Bezděková ², Michal Uher ³ and Jiří Jarkovský ⁴, ¹Institute of Rheumatology, Prague, Prague, Czech Republic, ²Institute of Health Information and Statistics of the Czech Republic, Praha, Hlavni mesto Praha, Czech Republic, ³Institute of Health Information and Statistics of the Czech Republic, and Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic, Brno, Czech Republic, ⁴Institute of Health Information and Statistics of the Czech Republic, and Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic, Praha, Hlavni mesto Praha, Czech Republic
Background/Purpose: To describe the epidemiology of Rheumatoid Arthritis (RA) in the Czech Republic (CZ)Methods: We used the administrative database of the National Registry of Reimbursed…
Abstract Number: 1103 • 2019 ACR/ARP Annual Meeting
Prevalence of Diagnosed Systemic Lupus Erythematosus (SLE), Patient Healthcare Utilization and Characteristics by Major Health Insurance Types in the US
Yiting Wang¹, Laura Hester ¹, Jennifer Lofland ², Shawn Rose ³, Chetan Karyekar ⁴, Dave Kern ⁵, Margaret Blacketer ¹, Kourtney Davis ¹ and Kimberly Shields-Tuttle ⁶, ¹Janssen Research & Development, LLC, Titusville, ²Janssen Scientific Affairs, LLC, Spring House, PA, ³Janssen Research & Development, LLC, Spring House, PA, ⁴Janssen Global Services, LLC, Horsham, PA, ⁵Janssen Scientific Affairs, Titusville, ⁶Janssen Research & Development, LLC, Spring House
Background/Purpose: One study estimated that between 161,000 and 322,000 people in the US had definite or probable SLE, based on data from the period of…
Abstract Number: 2054 • 2019 ACR/ARP Annual Meeting
Epidemiology of Gout in South Korea with the National Health Insurance Corporation Database
Jinsu Park¹, Jung-Soo Song ², Minjin Kang ³ and Chan Hee Lee ⁴, ¹Division of Rheumatology, Department of International Medicine, National Health Insurance Service Ilsan hospital, Goyang-si, Republic of Korea, ²Chung-Ang University College of Medicine, Seoul, Republic of Korea, ³Research and analysis Team, NHIS Ilsan hospital, Goyang-si, Republic of Korea, ⁴Division of Rheumatology, Department of Internal Medicine, National Health Insurance Service Ilsan Hospital, Goyang, Republic of Korea
Background/Purpose: Gout is the most common inflammatory arthritis that results from chronic elevation of uric acid levels above the saturation point for monosodium urate crystal…
Abstract Number: 1418 • 2014 ACR/ARHP Annual Meeting
Prevalence of Vitamin D Deficiency in Rheumatoid Arthritis
Stella Cecchetti¹, Martin Soubrier², Pilar Galan^3,4, Bruno Pereira⁵, Gael Mouterde⁶ and Maxime Dougados⁷, ¹Rheumatology department, CHU Gabriel Montpied, 63000, France, ²Rheumatology, CHU G.-Montpied, Clermont-Ferrand, France, ³Nutritional Epidemiology Research Unit, INSERM (U1153), Bobigny, France, ⁴Université Paris 13, Sorbonne Paris Cité, Paris Cité, France, ⁵Clinical research department, Clermont-Ferrand, France, ⁶Immunologie Rhumatologie, Hopital Lapeyronie, Montpellier, France, ⁷RAID working group for EULAR, Zurich, Switzerland
Background/Purpose Serum levels of vitamin D (VitD) are usually inversely correlated with RA activity. However, the prevalence of VitD deficiency does not appear to differ…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].